CML is associated with a recurrent genetic aberration, the Philadelphia (Ph) chromosome, formed through the translocation between chromosomes 9 and 22 and giving the constitutively active tyrosine kinase P210 BCR/ABL1 [91,92]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.